Infrared Spectroscopic Studies of Protein Formulations Containing Glycine

Journal of Pharmaceutical Sciences

Volumn 93, Issue 5, 2004, Pages 1359-1366

  Meyer, Jeffrey D ^a,d   Bai, Shu Jun ^a   Rani, Meena ^b   Suryanarayanan, Raj ^b   Nayar, Rajiv ^c   Carpenter, John F ^a   Manning, Mark C ^a,e  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HTD Biosystems   (United States)

^d ZYMOGENETICS INC   (United States)

^e HTD BioSystems Colorado   (United States)

Author keywords

Crystallinity; Glycine; Infrared spectroscopy; Lyophilization; Protein formulation; X ray diffraction

Indexed keywords

AMIDE; EXCIPIENT; GLYCINE; PROTEIN;

ANALYTIC METHOD; ARTICLE; DRUG CONFORMATION; DRUG FORMULATION; DRUG STABILITY; INFRARED SPECTROSCOPY; SPECTRAL SENSITIVITY;

EID: 1942434661     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20019     Document Type: Article

References (28)

1. Akers MJ, Milton N, Byrn SR, Nail SL. 1995. Glycine crystallization during freezing: The effects of salt form, pH, and ionic strength. Pharm Res 12: 1457-1461.
2. Yu L, Ng K. 2002. Glycine crystallization during spray drying: The pH effect on salt and polymorphic forms. J Pharm Sci 91:2367-2375.
3. Pyne A, Suryanarayanan R. 2001. Phase transitions of glycine in frozen aqueous solutions and during freeze-drying. Pharm Res 18:1448-1454.
4. Chongprasert S, Knopp SA, Nail SL. 2001. Characterization of frozen solutions of glycine. J Pharm Sci 90:1720-1728.
5. Prestrelski SJ, Tedeschi N, Arakawa T, Carpenter JF. 1993. Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. Biophys J 65:661-671.
6. Carpenter JF, Prestrelski SJ, Dong A. 1998. Application of infrared spectroscopy to development of stable lyophilized protein formulations. Eur J Pharm Biopharm 45:231-238.
7. Wang W. 2000. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 203: 1-60.
8. Izutsu K, Kojima S. 2002. Excipient crystallinity and its protein-structure-stabilizing effect during freeze-drying. J Pharm Pharmacol 54:1033-1039.
9. Pikal MJ, Dellerman KM, Roy ML, Riggin RM. 1991. The effects of formulation variables on the stability of freeze-dried human growth hormone. Pharm Res 8:427-436.
10. Carpenter JF, Izutsu K, Randolph TW. 1999. Freezing- and drying-induced perturbations of protein structure and mechanisms of protein protection by stabilizing additives. In: Rey L, Lee JC, editors. Freeze-drying/lyophilization of pharmaceutical and biological products. Drugs and the pharmaceutical sciences. New York: Marcel Dekker, pp 123-160.
11. Surana R, Suryanarayanan R. 2000. Quantification of crystallinity in substantially amorphous pharmaceuticals and study of crystallization kinetics by XRD. Powder Diffraction 15:2-6.
12. Black DB, Livering EG. 1977. Estimation of the degree of crystallinity in digoxin by X-ray and infrared methods. J Pharm Pharmacol 29:684-687.
13. Patel AD, Luner PE, Kemper MS. 2001. Low-level determination of polymorph composition in physical mixtures by near-infrared reflectance spectroscopy. J Pharm Sci 90:360-370.
14. Saleki-Gerhardt A, Ahlneck C, Zografi G. 1994. Assessment of disorder in crystalline solids. Int J Pharm 101:237-247.
15. Sebhatu T, Angberg M, Alhneck C. 1994. Assessment of the degree of disorder in crystalline solids by isothermal microcalorimetry. Int J Pharm 104: 135-144.
16. Taylor LS, Zografi G. 1998. The quantitative analysis of crystallinity using FT-Raman spectroscopy. Pharm Res 15:755-761.
17. Kamat MS, Osawa T, DeAngelis RJ, Koyama Y, DeLuca PP. 1988. Estimation of the degree of crystallinity of cefazolin sodium by X-ray and infrared methods. Pharm Res 5:426-429.
18. Kasraian K, Spitznagel TM, Juneau JA, Yim K. 1998. Characterization of the sucrose/glycine/water system by differential scanning calorimetry and freeze-drying microscopy. Pharm Dev Technol 3: 233-239.
19. Dong A, Huang P, Caughey WS. 1990. Protein secondary structures in water from 2nd derivative amide I infrared spectra. Biochemistry 29:3303-3308.
20. Kendrick BS, Dong A, Allison SD, Manning MC, Carpenter JF. 1996. Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states. J Pharm Sci 85: 155-158.
21. Carrasquillo KG, Stanley AM, Aponte-Carro JC, De Jesus P, Costantino HR, Bosques CJ, Griebenow K. 2001. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J Control Release 76:199-208.
22. Carrasquillo KG, Carro JC, Alejandro A, Toro DD, Griebenow K. 2001. Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation. J Pharm Pharmacol 53:115-120.
23. Fu K, Griebenow K, Hsieh L, Klibanov AM, Langer R. 1999. FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. J Control Release 58:357-366.
24. Yang TH, Dong A, Meyer J, Johnson OL, Cleland JL, Carpenter JF. 1999. Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. J Pharm Sci 88:161-165.
25. Luner PE, Majuru S, Seyer JJ, Kemper MS. 2000. Quantifying crystalline form composition in binary powder mixtures using near-infrared reflectance spectroscopy. Pharm Dev Technol 5:231-246.
26. Patel AD, Luner PE, Kemper MS. 2001. Low-level determination of polymorph composition in physical mixtures by near-infrared reflectance spectroscopy. J Pharm Sci 90:360-370.
27. Seyer JJ, Luner PE. 2001. Determination of indomethacin crystallinity in the presence of excipients using diffuse reflectance near-infrared spectroscopy. Pharm Dev Technol 6:573-578.
28. Hogan SE, Buckton G. 2001. Water sorption/desorption - Near IR and calorimetric study of crystalline and amorphous raffinose. Int J Pharm 227:57-69.